<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-22T07:57:45Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/FE0CAAA4-5A31-4AFC-88B9-ED17348A6861" ns1:id="FE0CAAA4-5A31-4AFC-88B9-ED17348A6861"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/32B8127D-FA34-47F2-8BF7-9A5127BE784F" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/7E031366-35DD-4B5D-A72E-2B81E97A9250" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/7E031366-35DD-4B5D-A72E-2B81E97A9250" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2015-07-30T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/75330EF0-2865-4179-B51E-A1BDC7346075" ns1:rel="FUND" ns1:start="2015-02-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">700506</ns2:identifier></ns2:identifiers><ns2:title>Novel Advanced SCI Instrumentation for CMC Joint</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>GRD Proof of Market</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>The joint at the base of the thumb is referred to as the carpometacarpal (CMC) joint. CMC
joint wears &amp;amp; develop arthritis. Osteoarthritis (OA) is the most common form of arthritis,
causing loss of movement, stiffness, pain, &amp;amp; ultimately surgery is required. Surgical options
are:
1) Trapeziectomy - removal of arthritic bone
2) Arthrodesis - fusion of the bone
3) Total joint replacement (TJR)
4) Metacarpal osteotomy - bone fragments cut/modified
5) Early stem cell technology
6) Denervation - small nerves divided, to relieve pain.
Most operations for CMC joint OA have lengthy recovery after surgery &amp;amp; impaired pinch
strength.
Cartiva Inc. developed a Synthetic Cartilage Implant (SCI); a polyvinyl alcohol (PVA)
cryogel that mimics natural cartilage. SCI is currently used as an effective surgical option for
OA, treating defects in the foot 1st/2nd Metatarsal Phalangeal Joint (MTPJ) providing fast
recovery, being less invasive than Total Joint Replacement (TJR) &amp;amp; used as intermediate
treatment to postpone or possibly eradicate TJR. Studies have shown that grip &amp;amp; pinch
strength are significantly improved &amp;amp; nearly full range of motion returns when using SCI for
CMC joint OA. The Cartiva™ SCI could treat early stage lesions in the CMC joint &amp;amp; provide
additional years of joint health &amp;amp; active lifestyle, potentially eradicating TJR &amp;amp; revisional
surgery.
The MTPJ SCI, does not match the saddle joint configuration of the CMC joint, therefore,
Cartiva Inc. propose to develop a saddle shaped SCI to match the biomechanics of the CMC
joint. MTPJ SCI instrumentation would not be compatible with a saddle shaped SCI. B-UK
propose to research the CMC joint market to see if extending the companies technology into
this market would be a good return of investment with hopes to ultimately develop single use
instrumentation that delivers 1) Ease of handling 2) implant loading, control &amp;amp; orientation
during delivery 3) implantation mechanism 4) Single use</ns2:abstractText></ns2:project>